Blood-clotting wound dressings are limited by their need for refrigeration and short shelf life: their component proteins tend to break down. Egea Biosciences in San Diego is developing (under Army contract) a compression bandage-the type used for major wounds-coated with a blood-clotting substance that might avoid those limitations.
The dressing is a variant of the fibrinogen that the body produces to promote clotting. A key ingredient is a protein found in spider silk, says Egea CEO Glen A. Evans. This protein could form clots for large wounds that otherwise would continue to bleed. The synthetic powder does not degrade over time or need refrigeration. It is several years from commercial introduction.
The big new idea for making self-driving cars that can go anywhere
The mainstream approach to driverless cars is slow and difficult. These startups think going all-in on AI will get there faster.
Inside Charm Industrial’s big bet on corn stalks for carbon removal
The startup used plant matter and bio-oil to sequester thousands of tons of carbon. The question now is how reliable, scalable, and economical this approach will prove.
The dark secret behind those cute AI-generated animal images
Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.
The hype around DeepMind’s new AI model misses what’s actually cool about it
Some worry that the chatter about these tools is doing the whole field a disservice.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.